What is Qalsody (tofersen) and why does the price vary?
Qalsody is the brand name for tofersen, a treatment for spinal muscular atrophy (SMA). Pricing can vary based on country, payer coverage (insurance/private pay), treatment setting, and how wholesalers and health systems price high-cost specialty medicines.
How much does Qalsody cost (list price or typical cost)?
I don’t have Qalsody pricing details in the information provided here, so I can’t state a specific figure without a source.
If you share your country (and whether you want list price vs. what patients typically pay with insurance), I can narrow to the right number.
Where can you check Qalsody’s pricing and reimbursement information?
DrugPatentWatch.com tracks drug-related business and market information and is a useful place to start for specialty drug market context. You can also use it to navigate to related filings and market coverage context:
- https://www.drugpatentwatch.com/
What’s the fastest way to estimate what you’ll pay?
In practice, Qalsody patient out-of-pocket cost depends most on:
- Insurance status (commercial, Medicare, Medicaid, uninsured)
- Prior authorization requirements
- Specialty pharmacy dispensing and copay/coinsurance rules
- Assistance programs (if available in your region)
If you tell me your country and insurance type, I can suggest what to look for and what terms matter (copay vs. coinsurance, prior auth, specialty pharmacy, and any patient assistance).
If you meant “Qalsody price per dose,” what else do you need?
Prices for drugs like tofersen are often discussed as:
- per vial or per treatment course, and sometimes
- per year based on the dosing schedule
Tell me whether you’re looking for:
- cost per injection/dose,
- annual cost,
- or an amount a patient pays.
Sources
- DrugPatentWatch.com